78 related articles for article (PubMed ID: 18515982)
1. Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer.
Kalender ME; Sevinc A; Camci C; Turk HM; Karakok M; Akgul B
Oncology; 2007; 73(5-6):415-8. PubMed ID: 18515982
[TBL] [Abstract][Full Text] [Related]
2. Hemicentral retinal artery occlusion in a breast cancer patient using anastrozole.
Karagöz B; Ayata A; Bilgi O; Uzun G; Unal M; Kandemir EG; Ozgün A; Türken O
Onkologie; 2009 Jul; 32(7):421-3. PubMed ID: 19556821
[TBL] [Abstract][Full Text] [Related]
3. Resolution of endometrial hyperplasia with adjuvant anastrozole treatment in postmenopausal breast cancer: a case report.
Stilwill SE; Cooper BC
J Reprod Med; 2007 Oct; 52(10):979-80. PubMed ID: 17977182
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive effects of anastrozole in a premenopausal breast cancer model.
Kubatka P; Sadlonová V; Kajo K; Nosál'ová G; Ostatníková D; Adamicová K
Anticancer Res; 2008; 28(5A):2819-23. PubMed ID: 19035316
[TBL] [Abstract][Full Text] [Related]
5. Retinal hemorrhages in anastrozole users.
Eisner A; Falardeau J; Toomey MD; Vetto JT
Optom Vis Sci; 2008 May; 85(5):301-8. PubMed ID: 18451730
[TBL] [Abstract][Full Text] [Related]
6. Information provision for patients by breast cancer teams about the side-effects of hormone treatments.
McGurk R; Fallowfield L; Winters Z
Eur J Cancer; 2006 Aug; 42(12):1760-7. PubMed ID: 16790339
[TBL] [Abstract][Full Text] [Related]
7. [A case of crescentic glomerulonephritis developed under oral anastrozole treatment].
Yoshimoto S; Nakatani K; Maruyama N; Fujiki K; Nakano T; Ueshima K; Fujimoto T; Oka H; Ishikawa H; Inoue F
Gan To Kagaku Ryoho; 2013 Feb; 40(2):267-70. PubMed ID: 23411970
[TBL] [Abstract][Full Text] [Related]
8. Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels.
Geisler J; Helle H; Ekse D; Duong NK; Evans DB; Nordbø Y; Aas T; Lønning PE
Clin Cancer Res; 2008 Oct; 14(19):6330-5. PubMed ID: 18829517
[TBL] [Abstract][Full Text] [Related]
9. Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer.
Schwartzberg LS; Cobb P; Senecal F; Henry D; Kulig K; Walker MS; Houts AC; Stepanski EJ
Breast; 2009 Apr; 18(2):78-83. PubMed ID: 19342237
[TBL] [Abstract][Full Text] [Related]
10. A case of brain metastases from breast cancer that responded to anastrozole monotherapy.
Ito K; Ito T; Okada T; Watanabe T; Gomi K; Kanai T; Mochizuki Y; Amano J
Breast J; 2009; 15(4):435-7. PubMed ID: 19470131
[No Abstract] [Full Text] [Related]
11. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
[TBL] [Abstract][Full Text] [Related]
12. Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
Psychooncology; 2009 Aug; 18(8):811-21. PubMed ID: 19085975
[TBL] [Abstract][Full Text] [Related]
13. Review of the ATAC study: tamoxifen versus anastrozole in early-stage breast cancer.
Needleman SJ; Tobias JS
Expert Rev Anticancer Ther; 2008 Dec; 8(12):1871-81. PubMed ID: 19046107
[TBL] [Abstract][Full Text] [Related]
14. Primary uterine rhabdomyosarcoma in a patient with a history of breast cancer and gastrointestinal stromal tumor.
Gottwald L; Gora E; Korczynski J; Piekarski JH; Morawiec Z; Jesionek-Kupnicka D; Sowa P; Cialkowska-Rysz A; Bienkiewicz A
J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):721-5. PubMed ID: 18840190
[TBL] [Abstract][Full Text] [Related]
15. Biological profile of oestrogen receptor positive primary breast cancers in the elderly and response to primary endocrine therapy.
Okunade G; Green AR; Ying M; Agrawal A; Paish EC; Aleskandrany M; Winterbottom L; Hassell K; Morgan DA; Ellis IO; Cheung KL
Crit Rev Oncol Hematol; 2009 Oct; 72(1):76-82. PubMed ID: 19515574
[TBL] [Abstract][Full Text] [Related]
16. Erythema multiforme after radiotherapy with aromatase inhibitor administration in breast-conservation treatment for breast cancer.
Nakatani K; Matsumoto M; Ue H; Nishioka A; Tanaka Y; Kodama H; Sasaguri S; Ogawa Y
Breast Cancer; 2008; 15(4):321-3. PubMed ID: 18278432
[TBL] [Abstract][Full Text] [Related]
17. Start strong or switch? Adjuvant endocrine strategies for postmenopausal women with hormone-sensitive breast cancer.
Tusquets Trías de Bes I; Tormo SS; Mestres JA
Biomed Pharmacother; 2009 Jan; 63(1):1-10. PubMed ID: 18539426
[TBL] [Abstract][Full Text] [Related]
18. Alleviating anastrozole induced bone toxicity by selenium nanoparticles in SD rats.
Vekariya KK; Kaur J; Tikoo K
Toxicol Appl Pharmacol; 2013 Apr; 268(2):212-20. PubMed ID: 23415680
[TBL] [Abstract][Full Text] [Related]
19. Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
Tang SC
Cancer Invest; 2008 Jun; 26(5):481-90. PubMed ID: 18568770
[TBL] [Abstract][Full Text] [Related]
20. Persistent bilateral ureteral obstruction secondary to endometriosis despite treatment with an aromatase inhibitor.
Bohrer J; Chen CC; Falcone T
Fertil Steril; 2008 Nov; 90(5):2004.e7-9. PubMed ID: 18555228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
